Members have received a letter from the PCRS highlighting above-average quantities of GTN sprays being claimed under the Community Drug Schemes. The issue has been successfully resolved when the clinical reason for the above-average usage was outlined, supported by a letter from the patient’s GP.
If you receive a similar letter and require guidance in responding to it, please contact the Contracts Department (contract@ipu.ie) for assistance.
